CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 81  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1262
LYS 10.0349
GLU 20.0084
LEU 30.0355
ARG 40.0263
CYS 50.0174
GLN 60.0295
CYS 70.0316
ILE 80.0118
LYS 90.0367
THR 100.0099
TYR 110.0090
SER 120.0123
LYS 130.0117
PRO 140.0172
PHE 150.0200
HIS 160.0172
PRO 170.0167
LYS 180.0269
PHE 190.0237
ILE 200.0123
LYS 210.0222
GLU 220.0207
LEU 230.0094
ARG 240.0260
VAL 250.0428
ILE 260.0190
GLU 270.0514
SER 280.0834
GLY 290.1262
PRO 300.0808
HIS 310.0302
CYS 320.0319
ALA 330.0349
ASN 340.0273
THR 350.0219
GLU 360.0121
ILE 370.0157
ILE 380.0153
VAL 390.0066
LYS 400.0115
LEU 410.0095
SER 420.0089
ASP 430.0125
GLY 440.0085
ARG 450.0098
GLU 460.0186
LEU 470.0125
CYS 480.0130
LEU 490.0091
ASP 500.0073
PRO 510.0160
LYS 520.0226
GLU 530.0178
ASN 540.0228
TRP 550.0111
VAL 560.0068
GLN 570.0113
ARG 580.0146
VAL 590.0128
VAL 600.0087
GLU 610.0059
LYS 620.0125
PHE 630.0075
LEU 640.0147
LYS 650.0316
ARG 660.0210
ALA 670.0340
GLU 680.0119
ASN 690.0175

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.